Topic resource collection
Approved comparison material connected to this topic.
3 resourcesRead both sides
Thymosin Alpha-1 TLR9 activation → T-cell maturation, interferon-alpha production 1.6mg subcutaneous Twice weekly Phase 3 trials in hepatitis B/C showed 30–40% viral load reduction; 50–60% reduction in infection recurrence in imm…
DSIP (Delta Sleep-Inducing Peptide) GABA-A receptor modulation in VLPO, reduces arousal-system hyperactivity 90–120 min before target sleep time 100–500 mcg subcutaneous 22–38 min reduction vs baseline (12-week RCT, European Slee…
The table below compares the receptor targets, half-lives, clinical trial outcomes, and practical considerations for the most studied weight loss & metabolic peptides as of 2026. Semaglutide GLP-1 receptor agonist ~7 days 14.9% a…